Dysregulation of cadherins in the intercalated disc of the spontaneously hypertensive stroke-prone rat by Craig, Margaret Anne et al.
Journal of Molecular and Cellular Cardiology 48 (2010) 1121–1128
Contents lists available at ScienceDirect
Journal of Molecular and Cellular Cardiology
j ourna l homepage: www.e lsev ie r.com/ locate /y jmccOriginal article
Dysregulation of cadherins in the intercalated disc of the spontaneously hypertensive
stroke-prone rat
Margaret Anne Craig, Martin W. McBride, Godfrey Smith, Sarah J. George 1, Andrew Baker ⁎
BHF Glasgow Cardiovascular Research Centre, University of Glasgow, 126 University place, Glasgow, G12 8TA, UK⁎ Corresponding author. Tel.: +44 0141 211 2100; fa
E-mail address: A.Baker@clinmed.gla.ac.uk (A. Baker
1 Bristol Heart Institute, Level 7 Bristol Royal Inﬁrmar
0022-2828/$ – see front matter © 2010 Elsevier Ltd. A
doi:10.1016/j.yjmcc.2010.01.017a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 May 2009
Received in revised form 19 December 2009
Accepted 26 January 2010
Available online 6 February 2010
Keywords:
E-cadherin
β-catenin
Cardiac hypertrophy
Intercalated discThe structural integrity of cardiac cells is maintained by the Ca2+-dependent homophilic cell–cell adhesion
of cadherins. N-cadherin is responsible for this adhesion under normal physiological conditions. The role of
cadherins in adverse cardiac pathology is less clear. We studied the hearts of the stroke-prone spontaneously
hypertensive (SHRSP) rat as a genetic model of cardiac hypertrophy and compared them to Wistar–Kyoto
control animals. Western blotting of protein homogenates from 12-week old SHRSP animals indicated that
similar levels of β, γ-, and α-catenin and T, N and R-cadherin were expressed in the control and SHRSP
animals. However, dramatically higher levels of E-cadherin were detected in SHRSP animals compared to
controls at 6, 12 and 18 weeks of age. This was conﬁrmed by quantitative Taqman PCR and immuno-
histochemistry. E-cadherin was located at the intercalated disc of the myocytes in co-localisation with
connexin 43. Adenoviral overexpression of E-cadherin in rat H9c2 cells and primary rabbit myocytes resulted
in a signiﬁcant reduction in myocyte cell diameter and breadth. E-cadherin overexpression resulted in re-
localisation of β-catenin to the cell surface particularly to cell–cell junctions. Subsequent immunohisto-
chemistry of the hearts of WKY and SHRSP animals also revealed increased levels of β-catenin in the
intercalated disc in the SHRSP compared to WKY. Therefore, remodelling of the intercalated disc in the hearts
of SHRSP animals may contribute to the altered function observed in these animals.x: +44 0141 330 6997.
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The cadherins are a super-family of transmembrane glycopro-
teinsthat mediate homophilic, Ca2+-dependent cell–cell adhesion
[1–3]. The cadherin mediated cell–cell adhesion provides strong
intercellular bonds, which are dependent upon the association of the
cadherin carboxyterminal cytoplasmic domain to the central region
of β- or γ-catenin and p120 [4–6]. β- and γ-catenin bind α-catenin,
in turn promote the anchorage of the complex to the actin cytoskele-
ton. Free (non-cadherin associated) β-catenin associates in another
complex, containing the proteins adenomatous polyposis coli (APC),
axin, and glycogen synthase 3β (GSK3β), which targets β-catenin
for degradation.Wnt signalling initiated by the binding ofWnt to the
Frizzled receptors, antagonises this APC–axin–GSK3β complex, leading
to an increase in the pool of free cytoplasmic β-catenin resulting in
catenin translocation to the nucleus. Subsequently, β-catenin, in
association with T cell factor (TCF), regulates transcriptional activity
of numerous target genes, including the cell cycle genes cyclin D1,
p21, transcription factors such as c-myc, c-jun and Sox9 and extra-
cellular matrix regulatory genes such as ﬁbronectin, MT1-MMP and
MMP-7 [7–10].The members of the cadherin family have distinct spatial and
temporal patterns of expression during embryonic development and
in the adult. E-cadherin is expressed in most epithelia throughout the
body, while N-cadherin expression is more restricted to speciﬁc cell
types such as muscle and neurones [2,11]. The function of different
cadherin subtypes also depends on the cellular context. In support of
this, a switch in cadherin expression from E- to N-cadherin occurs in
many cancer types, leading to alterations in cell behaviour [12].
Although it is established that N-cadherin and E-cadherin are crucial
for cardiogenesis [13,14], to date, few studies have addressed the
expression and role of these cadherins in adult heart tissue. A study by
Kostetskii et al, illustrated that deletion of N-cadherin in the mouse
heart leads to dilated cardiomyopathy and impaired cardiac function
due to loss of N-cadherin-mediated anchorage of myoﬁbrils at the
plasma membrane [15]. This study highlights the absolute require-
ment for N-cadherin in the heart.
The SHRSP is a genetically bred model of hypertension with a high
incidence of cerebrovascular events and cardiac remodelling [16,17].
Cardiac hypertrophy is an adaptive response of the heart to increased
workload. However sustained cardiac hypertrophy may ultimately
lead to heart failure. The transition from compensated hypertrophy to
failure of the myocardium involves a complex of events; myocyte
growth or hypertrophy, changes in myocyte phenotype resulting
from re-expression of foetal gene programs and alterations in the
expression or function or both, of proteins involved in excitation–
Fig. 1. Cadherin and catenin expression in the SHRSP and WKY rat hearts. Western
blot analysis of heart extracts from 12-week old SHRSP and WKY animals (shown as 3
of each, n=9). (A) Western blot analysis from heart protein homogenates prepared
from animals 12 weeks of age indicated that the levels of β-, γ- and α-catenin were
all unchanged between the control and the SHRSP animals. (B) Levels of T-, N- and
R-cadherin also remained unchanged, however we observed a marked up-regulated
level of E-cadherin from low levels in the WKY to readily detectable levels in the
SHRSP. (C) Further analysis of heart homogenates from 6, 12 and 18 week old animals
showed these cadherin levels were up-regulated from as early as 6 weeks of age
through to 18 weeks.
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extracellular matrix. Together these events result in changes in
myocardial structure (e.g. increased myocardial mass, chamber
dilatation) and function, often leading to further pump dysfunction
and haemodynamic overload [18]. Based on these observations we
hypothesised that cadherins may be dysregulated in the remodelling
associated with the hearts of the SHRSP model and any alteration in
expression may contribute to the alteration in the mechanical and
electrical activity observed in these hearts.
2. Methods
2.1. Animals
Inbred colonies of SHRSP and Wistar–Kyoto (WKY) rats were
maintained at the University of Glasgow as described previously [19].
All rats were housed under controlled conditions of temperature
(21 °C) and light and maintained on normal rat chow (rat and mouse
No. 1 maintenance diet, Special Diet Services, Witham, Essex, UK) and
water freely available. These animal studies were approved by the
Home Ofﬁce according to regulations regarding experiments with
animals in the UK.
2.2. Evaluation of cadherin expression in the myocardium of SHRSP and
WKY rats
6, 12 and 18-week old SHRSP animals and WKY controls were
euthanized and hearts removed. Tissue was divided and processed for
protein homogenates, RNA extraction and immunohistochemistry.
For western blotting, proteins were electrophoresed and transferred
ontoHybond-Pmembrane (AmershamBioscience, Buckingham, U.K.),
and blocked with 10% (wt/vol) skimmed milk powder in TBS-T
(150 mMNaCl, 50 mMTris, 0.1% (v/v) Tween-20). Themembranewas
incubated for 1 h at 37 °C with the following antibodies, N-cadherin,
E-cadherin, R-cadherin, T-cadherin, β-catenin, γ-catenin, α-catenin
and GAPDH as the loading control (BD Biosciences, Oxford, U.K.).
Proteins were visualised using an ECL detection system (Amersham
Biosciences, U.K.). For quantiﬁcation of mRNA levels, quantitative
Real-Time PCR was used. Heart RNA was extracted from 12-week
old rats using RNeasy kits (Qiagen, West Sussex, U.K.), treated
with DNase Free (Ambion, Warrington, U.K.), and quantiﬁed using
Nanodrop (Labtech, East Sussex, U.K.). Normalisation was conﬁrmed
by performing real-time PCR (Taqman, Applied Biosystems, Califor-
nia, U.S.A.) of Actβ (β-actin; Applied Biosystems) with comparable
threshold cycles. Taqman probe for E-cadherin (Rn00580109_m1-
labelled FAM) were multiplexed with Actβ (4352340E-labelled VIC).
Expression of E-cadherin relative to Actβ was derived using
the comparative (2−ΔΔct) method and is shown as fold change [20].
PCR primers were designed to exon 1 and 16 around SNP1 and SNP2
identiﬁed on the Ensembl web site using BN genome sequence
as a template. PCR products were prepared with the Agencourt
AMPure PCR Puriﬁcation system (Agencourt Bioscience, Buckin-
ghamshire, U.K.) and sequenced with BigDye v3.1 ﬂuorescent nucle-
otides (Applied Biosystems). Sequencing reactions were puriﬁed
with the Agencourt CleanSEQ Sequencing Reaction Clean-Up system
and run on the ABI 3730 using polymer 7 and DNA sequence analysed
with SeqScape version 2.5 (Applied Biosystems). For immuno-
histochemistry, formalin-ﬁxed parafﬁn-embedded tissue sections
(6 µm) were sequentially deparafﬁnised and rehydrated through
an alcohol gradient. Tissue sections were incubated with primary
anti-E-cadherin, N-cadherin and β-catenin antibodies or matched
mouse IgG non-immune control (Dako, Denmark) followed by
detection with biotinylated universal secondary antibody (1/200),
ABC Kit and standard diaminobenzidine staining. Sections were
counterstained with haematoxylin. Serial sections were also stained
Fig. 2. Altered E-cadherin expression. (A) Taqman gene expression analysis of RNA extracted from the hearts of 12-week old SHRSP and WKY animals. Data shows a signiﬁcant
increase in expression of E-cadherin in the SHRSP group and is shown as relative fold change (n=6). (B) Genome organisation of E-cadherin. Sequence analysis identiﬁed a
nucleotide change for SNP1 located in the non-coding region of exon 1.
Fig. 3. Histological analysis of hearts from the SHRSP andWKY. Histological analysis was carried out on the hearts of 12-week oldWKY and SHRSP animals. (A) There appeared to be
no difference in levels of N-cadherin between the SHRSP animals and theWKY controls. Immunohistochemistry of tissue sections for E-cadherin demonstrated up-regulated levels of
E-cadherin in the SHRSP compared to the WKY control (scale=25 µm). (B) Immunohistochemical staining of SHRSP hearts showing localisation of E-cadherin to the intercalated
disc similar to the adherens junction marker connexin 43 (scale=25 µm).
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localisation of β-catenin and E-cadherin.
2.3. Construction and propagation of Ad vectors
Adenovirus to overexpress E-cadherin was a gift from Dr D. Jean,
University of Sherbrooke, Quebec [21]. Positive plaques were ampli-
ﬁed and tested for E-cadherin expression by Western blot analysis.
Plaques expressing E-cadherin were ampliﬁed and the titer of virus
stocks was determined by plaque assay on 293T cells [22].
2.4. In vitro assessment of myocyte structure
New ZealandWhite rabbits (2–2.5 kg) were euthanized by admin-
istration of an intravenous injection of 500 IU heparin together
with an overdose of sodium pentobarbitone (100 mg/kg). Hearts
were removed and perfused retrogradely (25 ml/min, 37 °C) with a
nominally Ca2+ free Krebs–Henseleit solution supplemented with
0.6 mg/ml collagenase and 0.1 mg/ml protease for 6 min. Perfused
tissue was ﬁnely dissected and ﬁltered through gauze to give a
cardiomyocyte cell suspension. To assess the effects of E-cadherin
overexpression on function and structure of single cardiomyocytes,
Primary rabbit myocytes or H9c2 (a myogenic cell-line derived from
embryonic rat ventricle) cells were counted, and adenoviral infection
was performed during plating of the myocytes at 3×104 rod-shaped
cells into Petri dishes with either Ad:E-cadherin or Ad:LacZ with an
indicated multiplicity of infection (MOI). Myocytes were cultured in
supplemented M199 medium (Sigma) for 48 h. The lysate of cells
transfected with Ad–E-cadherin were subjected to western immuno-Fig. 4. Adenovirusmediated in vitro overexpression of E-cadherin. Isolated single adult rabbit
from extracts of H9c2 cells infected with E-cadherin showing increasing levels of E-c
(B) Immunocytochemical levels of E-cadherin in H9c2 cells infected with either Ad:E-cadher
at low and high levels of infection (scale=25 µm).blotting as before. Infection of H9c2 and isolated rabbit myocytes with
increasing doses of Ad:E-cadherin allowed for the effects of dose
response on hypertrophy to be assessed by the calculation of cell
volume. Cell length was measured 48 h post-transfection. Samples of
the cell suspension were placed on a glass slide and measured with a
graticule in the eye-piece of the microscope and cell volume cal-
culated (n=50 per group).
2.5. Immunocytochemistry of H9c2 cells infected with the E-cadherin
adenovirus
H9c2 cells were infected with either the Ad:E-cadherin or Ad:LacZ
at an MOI of 30. 48 h later the cells were washed in PBS and ﬁxed
with 10% formaldehyde. Fixed cells were incubatedwith primary anti-
E-cadherin, N-cadherin and β-catenin antibodies or matched mouse
IgG non-immune control (Dako, Denmark) followed by detection
with FITC conjugated universal secondary antibody. The cells were
mounted with vectashield with DAPI and visualised by ﬂuorescent
microscopy.
2.6. Immunoprecipitation of E-cadherin with β-catenin
H9c2 cells were grown in a monolayer and infected with either
Ad:E-cadherin or Ad:LacZ at an MOI of 30. Following 48 h, the cells
were harvested in RIPA buffer. Equal protein concentrations of
the lysed cells were incubated with either β-catenin-agarose con-
jugated antibody or IgG-agarose conjugated control at 4 °C over-
night. A separate sample of Ad-transduced cells was incubated
overnight without antibody and was used to quantify the total levelcells or H9c2 cells were infected with either Ad:E-cadherin or Ad:LacZ. (A)Western blot
adherin from differing multiplicities of infection and the GAPDH loading control
in or Ad:LacZ. Successful infection of E-cadherin into the H9c2 cell-line can be observed
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loading buffer added. The cell samplewas then probed for E-cadherin
as described before.
2.7. Statistical analysis
Comparisons were made using the student's t-test. Statistical
analysis was performed in Prism version 4.0 (Graph Pad Software,
CA, USA). For all tests, Pb0.05 is considered statistically signiﬁcant.
The results represent mean values and SEM of the data.
3. Results
We ﬁrst sought to assess whether cadherin/catenin expression
levels were modulated in the SHRSP compared to its normotensive
control strain WKY. Western blot analysis from heart protein homog-
enates prepared from animals 12 weeks of age indicated that the
levels of β-, γ- andα-catenin were all similar between the control and
the SHRSP animals, as were levels of T-, N- and R-cadherin (Fig. 1(A)).
However, we observed a marked up-regulation of E-cadherin
from low levels in the WKY to readily detectable levels in the SHRSP
(Fig. 1(B)). Further analysis of heart homogenates from 6, 12 and
18 week old animals showed E-cadherin levels were up-regulated
from as early as 6 weeks of age and still high at 18 weeks (Fig. 1(C)).
Taqman quantitative RT-PCR gene expression analysis conﬁrmed
signiﬁcantly elevated E-cadherin levels in the SHRSP animals
compared to WKY controls (Fig. 2(A)). The data suggests that there
is a 4.14-fold increase in the level of E-cadherin (WKY mean ΔCt=
12.86±0.50, SHRSP ΔCt=10.81±0.64, p=0.03). This suggests aFig. 5. Effect of E-cadherin overexpression on cell dimensions. Hearts from adult rabbits wer
Isolated single adult rabbit cells and H9c2 cells were infected with either Ad:E-cadherin or Ad
(A) Transduction of H9c2 cells with AD:E-cadherin resulted in signiﬁcantly decreased cel
resulted in cells with a signiﬁcantly decreased cell length and width resulting in an overalltranscriptional control mechanism that leads to E-cadherin over-
expression in the SHRSP rather than post-transcriptional control.
Interestingly, following ampliﬁcation of 5′ and 3′ regions of the rat
E-cadherin gene we observed a single nucleotide polymorphism in
the 5′ non-coding region (exon 1) between the SHRSP and WKY
(Fig. 2(B)).
We next evaluated the localisation of E- and N-cadherin in heart
sections from animals at 6, 12, and 18 weeks of age using immu-
nohistochemistry. N-cadherin was located in the intercalated disc as
expected. The levels of N-cadherin were similar in WKY and SHRSP
(Fig. 3(A)). In contrast, the levels of E-cadherin were higher in the
SHRSP animal compared to the WKY (Fig. 3(A)), conﬁrming the
western blotting and real-time PCR results. The E-cadherin staining
was located in the intercalated disc and was found to be co-localised
with connexin 43 (Fig. 3(B)).
We next sought to investigate the potential effect of E-cadherin
dysregulation in the heart by using an in vitromodel system. We used
rat H9c2 cells, an established cell model system for studies on
myocyte hypertrophy [23,24] as well as primary rabbit myocytes [25].
We ﬁrst used an adenovirus to overexpress E-cadherin in H9c2
cultures. Efﬁcient transduction and ectopic E-cadherin expressionwas
observed by western blot analysis and immunocytochemistry (Fig. 4).
E-cadherin overexpression resulted in a signiﬁcant decrease in H9c2
cell diameter (Fig. 5(A)). Overexpression of E-cadherin in the primary
rabbit myocytes also affected cell shape and size; a signiﬁcant reduc-
tion of both cell length and width resulting in an overall reduction of
cell volume was detected (Fig. 5(B)).
To ascertain the effect of E-cadherin overexpression on β-catenin
levels and localisation we assayed control and E-cadherin adenovirus-e excised and single cells enzymatically isolated using a Langendorff perfusion system.
:LacZ Cell dimensions were measured using a graticule in the eye-piece of a microscope.
l diameter (n=50/group). (B) Infection of rabbit myocytes with Ad:E-cadherin also
decrease in cell volume (n=50/group).
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levels of β-catenin staining in the cytoplasm. Increased expression of
E-cadherin resulted in selective localisation of β-catenin to the cell
surface especially in regions of cell–cell contact (Fig. 6(A)). Increased
expression of E-cadherin also resulted in greater than 50% of
cells having two or more nuclei. To assess whether β-catenin asso-
ciated with E-cadherin we performed co-immunoprecipitation
experiments. Western blotting for E-cadherin demonstrated inter-
action with β-catenin however, the results indicated that not all of the
E-cadherin was bound to β-catenin (Fig. 6(B)). Finally, we assessed
the localisation of β-catenin in vivo in the hearts of SHRSP and WKY
animals. β-catenin appeared to be selective to the intercalated disc in
SHRSP hearts (Figs. 6(C) and (D)).
4. Discussion
The structural and electrical integrity of ventricle muscle is main-
tained by the end-to-end connection between myocytes termed the
intercalated disc. In the adult heart this consists of three junctional
complexes; zona adherens, desmosomes and gap junctions [26]. The
reorganisation of homophilic cell–cell adhesion is mainly regulated by
the cadherin/catenin system, which is differentially modulated to
sustain cell structural rather than signalling needs. N-cadherin, which
is normally expressed in the adult heart is required formaintenance of
the structural integrity and myoﬁbril continuity across the plasma
membrane [27,28]. In the SHRSPmodel, levels of N-cadherin appeared
to be relatively unaltered compared to controls. However E-cadherinFig. 6. Localisation of β-catenin following E-cadherin overexpression. H9c2 cells were infec
β-catenin were analysed. (A) Immunocytochemistry of H9c2 cells overexpressing E-cadhe
cell-to-cell junctions (indicated by the arrows). Many of the infected cells also contained t
were lysed in RIPA buffer and undergone immunoprecipitation with either β-catenin or IgG
and therefore co-localises with β-catenin. (C) Immunohistochemical localisation of β-caten
localisation of β-catenin at the intercalated disc of the cell membrane in the SHRSP hearts
and SHRSP hearts showing localisation of β-catenin to the intercalated disc similar to thewas virtually absent in normotensive WKY animals consistent with
observations in the hearts of normal mice [29], was up-regulated
in the hearts of SHRSP rats, as assessed by immunohistochemistry,
western blot and Taqman PCR analysis at 6, 12 and 18 weeks of age.
However, the consequences of this alteration in cadherin type in the
myocardium in the SHRSP is unclear. A study in which E-cadherin was
substituted for N-cadherin in the heart of N-cadherin null mice,
caused premature death occurred prior to intercalated disc formation
and pathological features similar to that found in human end stage
heart disease [30]. Of note, E-cadherin overexpression led to DNA
synthesis and binucleated myocytes, associated with increased cyclin
D1 expression. Our in vitro studies also showed that overexpression of
E-cadherin into the H9c2 cell-line resulted in many of the cells having
two or more nuclei.
The detected increase in E-cadherin in SHRSP rat hearts may be a
result of altered transcriptional activity. Based on the published
sequence of the rat genome we have ampliﬁed two regions of the rat
E-cadherin gene by PCR from genomic DNA and assessed known
single nucleotide polymorphisms (SNPs). Of the two known SNPs, the
SNP positioned in the 5′ non-coding region of exon 1 was different
between WKY and SHRSP animals. This may have a further impact on
the effect of dysregulated E-cadherin expression in the SHRSP.
Although levels of the other cadherins and catenins appeared to be
unaltered, distribution of β-catenin was different. In E-cadherin over-
expressing cells, β-catenin was detected at cell–cell junctions and
in association with E-cadherin, which may restrict WNT/β-catenin
signalling. In heart development, β-catenin plays a biphasic role inted with either Ad:E-cadherin or Ad:LacZ and levels and localisation of N-cadherin and
rin showing up-regulation of β-catenin both in the cytoplasm but also markedly at the
wo or more nuclei (B) H9c2 cells infected with either Ad:E-cadherin or Ad:LacZ. Cells
control antibody. Western blot showing that much of the E-cadherin co-precipitates
in in the hearts of 12-week old SHRSP andWKY controls. There appears to be selective
(indicated by the arrows, scale=10 µm). (D) Immunohistochemical staining of WKY
adherens junction marker connexin 43 (scale=10 µm).
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cells to the cardiac lineage, while at later stages a down-regulation
is required for differentiation [31]. β-catenin levels are therefore
relatively high in the embryonic heart compared to the adult heart.
In hypertrophic cardiomyopathic hearts accumulation of β-catenin
particularly in the intercalated discs occurs as a result of Wnt expres-
sion, decrease in GSK-3β and different localization of APC [32].
The accumulation of β-catenin in intercalated discs is thought
to play a role in determining the previously described plasmalemma
rigidiﬁcation in δ-SG null cardiomyocytes [32]. This mechanism
could contribute to increased myocardial wall stiffness and left ven-
tricular end-diastolic pressure as well as to modify intercellular
electric impedance in hypertrophic cardiomyopathic hamsters and
men. In human hypertrophic cardiomyopathy there is also found
to be a remarkable accumulation of N-cadherin and β-catenin re-
sulting in enlarged and disorganised intercalated discs [32]. Over-
expression of E-cadherin in isolated cardiomyocytes and the H9c2
cell-line resulted in a signiﬁcant decrease in cell volume and more
rounded cells. The cell-to-cell adhesion that is associated with
cadherins, requires re-arrangement of the actin cytoskeleton. Loss
of N-cadherin results in the disassembly of the intercalated disc
structure, including adherens junctions and desmosomes. Decreased
sarcomere length and increased Z-line thickness were observed
in the mutant hearts consistent with loss of muscle tension because
N-cadherin was no longer able to anchor myoﬁbrils to the plasma
membrane [15]. We propose that introduction of E-cadherin into
these cell types may also result in disorganised myoﬁbril structure.
Conversely, it may result in a stiffening of myoﬁbril structure
and may contribute to the increased stiffness observed in cardiac
hypertrophy.
We have shown for the ﬁrst time that increased E-cadherin
and β-catenin are dysregulated in the hearts of the SHRSP and
therefore may contribute in the pathology of cardiac disease. This
association of aberrant pathology with E-cadherin/β-catenin has
however been observed in animal models of cancer such as colon
cancer [33]. Increased expression of E-cadherin in the crypts of the
colon results in the up-regulation of APC protein, some of which
enters the nucleus. There it makes the cells susceptible to the
eventual apoptotic balancing by stopping survivin expression and
the β-catenin–TCF-4 complex from driving further cell cycling by
releasing β-catenin from the ultimate proteasomal destruction.
Cytoplasmic β-catenin is then prevented from returning to the
nucleus by either being intercepted and destroyed by the APC–axin–
GSK-3β complexes or locked by the emerging E-cadherin into the
membrane adherens junctions, which tie the cell into a sheet of
proliferatively shut-down cells. In fact, the segregation of β-catenin
in intercalated disc implies that cytoplasmic β-catenin level is
lowered and nuclei are deprived of stimuli needed to maintain a
physiological gene activity.
To evaluate the effect of E-cadherin on cardiac function, we
transfected adult rabbit ventricular myocytes with E-cadherin adenovi-
rus and measured their fractional shortening in response to ﬁeld
stimulation. The cells overexpressing E-cadherin maintained normal
function (data not shown). Dependent on the intracellular Ca2+ concen-
tration, E-cadherin has been shown to assemble and increase the func-
tionof connexin43 [34].Therefore, re-introductionof the foetal oncogene
E-cadherinmay be a compensatorymechanism to up-regulate the levels
of connexins and therefore aid cardiac function. This mechanismmay be
further aided by relocation of β-catenin to the intercalated disc since
deletion of β-catenin in stress induced cardiac hypertrophy resulted in a
33% reduction in the expression of connexin 43 [35].
Dysregulation of the intercalated disc in the SHRSP model may
therefore result in alterations in structure and cell-signalling which
may contribute to the aberrant structure and function observed in
these animals. Together, these ﬁndings may provide an insight into
the pathology observed in heart disease.Acknowledgments
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